Volume | 3,007,602 |
|
|||||
News | - | ||||||
Day High | 0.00095 | Low High |
|||||
Day Low | 0.0008 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Therapeutic Solutions International Inc (PK) | TSOI | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0009 | 0.0008 | 0.00095 | 0.00085 | 0.0009 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
21 | 3,007,602 | US$ 0.000854 | US$ 2,569 | - | 0.0004 - 0.003 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:40:07 | 25,000 | US$ 0.00085 | USD |
Therapeutic Solutions International Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 3.09B | 303.59M | 99k | -2.17M | -0.00 | 0.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Therapeutic Solutions (PK) News
Date | Time | Source | News Article |
---|---|---|---|
5/31/2024 | 15:51 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
5/31/2024 | 11:47 | Edgar (US Regulatory) | Form 8-K - Current report |
5/31/2024 | 07:46 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
5/31/2024 | 07:44 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
5/30/2024 | 13:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
5/15/2024 | 11:01 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
5/06/2024 | 05:03 | Edgar (US Regulatory) | Form 8-K - Current report |
2/26/2024 | 13:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
2/26/2024 | 13:12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
2/21/2024 | 16:25 | Edgar (US Regulatory) | Form 8-K - Current report |
2/20/2024 | 05:16 | Edgar (US Regulatory) | Form 8-K - Current report |
2/07/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TSOI Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0008 | 0.0011 | 0.0006 | 0.0008402 | 31,476,927 | 0.00005 | 6.25% |
1 Month | 0.0008 | 0.0011 | 0.0005 | 0.0006904 | 39,899,607 | 0.00005 | 6.25% |
3 Months | 0.0011 | 0.0011 | 0.0004 | 0.0007126 | 30,573,920 | -0.00025 | -22.73% |
6 Months | 0.0011 | 0.0019 | 0.0004 | 0.0008497 | 22,101,670 | -0.00025 | -22.73% |
1 Year | 0.003 | 0.003 | 0.0004 | 0.0011382 | 17,569,433 | -0.00215 | -71.67% |
3 Years | 0.058 | 0.1345 | 0.0004 | 0.014983 | 11,117,125 | -0.05715 | -98.53% |
5 Years | 0.0026 | 0.172925 | 0.0004 | 0.0165859 | 11,803,188 | -0.00175 | -67.31% |
Therapeutic Solutions (PK) Description
Therapeutic Solutions International, Inc. is involved in the medical sciences market. We are focused on three different areas within the same market. They are outlined as follows: 1. Dietary Supplements 2. Immunotherapy Our business plan is twofold: 1. Produce and refine current product lines and develop them further, and 2. To focus on leveraging immunological processes to diagnose and intervene in niche areas of unmet medical needs. |